ARS Pharmaceuticals, Inc 10-K for FY2025
ARS Pharmaceuticals, Inc. (SPRY)
10-K
2026-03-09
For: 2025-12-31
View Original
Added on
April 11, 2026
About this 10-K
ARS Pharmaceuticals, Inc filed this 10-K on March 9, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $84.28M
- down 5.5% from $89.15M a year earlier
- Net loss
- $171.3M
- compared with net income of $8M a year earlier
- Diluted EPS
- -$1.74
- compared with $0.08 a year earlier